Evidence map›Paper›PMID 21685370›Full record

ArticleBlood2011

Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury.

Aparna Krishnamoorthy, Amrendra Kumar Ajay, Dana Hoffmann, Tae-Min Kim, Victoria Ramirez, Gabriela Campanholle, Norma A Bobadilla, Sushrut S Waikar, Vishal S Vaidya

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Prophylactic Fibrinogen Decreases Postoperative Bleeding but Not Acute Kidney Injury in Patients Undergoing Heart Transplantation.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2018
    Trial
  3. Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2014
    Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  11. Article
  12. Article
  13. The Fibrin Cleavage Product BβFrontiers in pharmacology · 2018
    Article
  14. Article
  15. Review
  16. MicroRNA-155 deficient mice experience heightened kidney toxicity when dosed with cisplatin.Toxicological sciences : an official journal of the Society of Toxicology · 2014
    Article
  17. Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.American journal of physiology. Renal physiology · 2014
    Article
  18. Review
  19. Impaired renal function and development in Belgrade rats.American journal of physiology. Renal physiology · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Aparna KrishnamoorthyRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Amrendra Kumar Ajay
Dana Hoffmann
Tae-Min Kim
Victoria Ramirez
Gabriela Campanholle
Norma A Bobadilla
Sushrut S Waikar
Vishal S Vaidya
Brigham and Women's Hospital · USCenter for Systems Biology · USUniversidad Nacional Autónoma de México · MX

Funding

Role of SMOC2 in Kidney FibrosisR01ES017543 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, VISHAL S. · 2011 to 2021
$3.9M
Technology and Endothelial Biology of Kidney Injury Molecule-1R00ES016723 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, VISHAL S. · 2008 to 2010
$983k
Technology and Endothelial Biology of Kidney Injury Molecule-1K99ES016723 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, VISHAL S. · 2007 to 2007
$90k
NIEHS NIH HHS ES16723NIEHS NIH HHS K99 ES016723NIEHS NIH HHS R00 ES016723NIEHS NIH HHS R01 ES017543
6 · The paper itself

Abstract

Ischemia/reperfusion (I/R) injury in the kidney is a major cause of acute kidney injury (AKI) in humans and is associated with significantly high mortality. To identify genes that modulate kidney injury and repair, we conducted genome-wide expression analysis in the rat kidneys after I/R and found that the mRNA levels of fibrinogen (Fg)α, Fgβ, and Fgγ chains significantly increase in the kidney and remain elevated throughout the regeneration process. Cellular characterization of Fgα and Fgγ chain immunoreactive proteins shows a predominant expression in renal tubular cells and the localization of immunoreactive Fgβ chain protein is primarily in the renal interstitium in healthy and regenerating kidney. We also show that urinary excretion of Fg is massively increased after kidney damage and is capable of distinguishing human patients with acute or chronic kidney injury (n = 25) from healthy volunteers (n = 25) with high sensitivity and specificity (area under the receiver operating characteristic of 0.98). Furthermore, we demonstrate that Fgβ-derived Bβ(15-42) peptide administration protects mice from I/R-induced kidney injury by aiding in epithelial cell proliferation and tissue repair. Given that kidney regeneration is a major determinant of outcome for patients with kidney damage, these results provide new opportunities for the use of Fg in diagnosis, prevention, and therapeutic interventions in kidney disease.

Indexed as

Acute Kidney InjuryAgedAmino Acid SequenceAnimalsApoptosisFemaleFibrin Fibrinogen Degradation ProductsFibrinogenHumansKidneyMaleMiceMice, Inbred C57BLMiddle AgedMolecular Sequence DataPeptide FragmentsFibrin Fibrinogen Degradation ProductsFibrinogenfibrinogen Bbeta (15-42)Peptide FragmentsRNA, Messenger

Identifiers

PMID21685370
PMCPMC3158721
OpenAlexW2037248386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.